SPOTLIGHT: The biotech investing commandments, part two

Continuing yesterday's article, part two of the Motley Fool's 10 commandments outlines what experts are telling investors to look for when it comes to biotech stocks. When all is said and done, author Brian Lawler points out, the best tip for investors is to do your homework. The only way to make a relatively low risk, high payoff investment in this volatile biotech market is to researcher a company's management, product, market and competition. By following these commandments, investors can take some of the guesswork out of buying into a biotech company. Article

Suggested Articles

Novartis is forging ahead with the development of spartalizumab in "many, many other indications" despite the setback.

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.